These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 605744)

  • 1. Dopaminergic stimulation of HGH in diabetes mellitus and in obesity.
    Gragnoli G; Palazzuoli V; Favilli R; Tanganelli I; Migliarese G
    Acta Diabetol Lat; 1977; 14(3-4):137-43. PubMed ID: 605744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Under-responsiveness of growth hormone secretion after L-dopa and deep sleep stimulation in obese subjects.
    Laurian L; Oberman Z; Ayalon D; Cordova T; Herzberg M; Horer E; Harell A
    Isr J Med Sci; 1975 May; 11(5):482-7. PubMed ID: 1158662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
    Shimoda S; Takemura Y; Ieiri T; Kasai K; Kikuchi T
    Nihon Naibunpi Gakkai Zasshi; 1975 Jan; 51(1):9-17. PubMed ID: 1171032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases].
    Mitsuhashi S; Yamasaki R; Miyazaki S; Saito H; Saito S
    Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):934-46. PubMed ID: 3123283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
    Maeda K; Kato Y; Chihara K; Ogo S; Iwasaki Y
    J Clin Endocrinol Metab; 1975 Aug; 41(2):408-11. PubMed ID: 239963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa-stimulated growth hormone secretion and diabetic retinopathy.
    Holland PM; Landers MB; Lebovitz HE; Wolbarsht ML
    Am J Ophthalmol; 1976 Oct; 82(4):612-8. PubMed ID: 970425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HGH secretion after oral application of L-dopa and L-carbidopa (author's transl)].
    Schönberger W; Ziegler R; Brodt B; Grimm W
    Eur J Pediatr; 1976 Jun; 122(3):195-200. PubMed ID: 1278188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone response to L-dopa in the thinned obese.
    Laurian L; Oberman Z; Hoerer E; Wiznitzer T; Harell A
    Isr J Med Sci; 1982 May; 18(5):625-9. PubMed ID: 7096047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced growth hormone response to L-dopa and pyridostigmine in obesity.
    Lee EJ; Kim KR; Lee KM; Lim SK; Lee HC; Lee JH; Lee DJ; Huh KB
    Int J Obes Relat Metab Disord; 1994 Jul; 18(7):465-8. PubMed ID: 7920871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sulpiride on serum growth hormone and prolactin concentrations following L-DOPA administration in man.
    Mori M; Kobayashi I; Shimoyama S; Uehara T; Nemoto T
    Endocrinol Jpn; 1977 Apr; 24(2):149-53. PubMed ID: 406134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hyperglycemia on the growth hormone response to L-dopa in diabetic subjects.
    Barbarino A; De Marinis L; Martino F
    J Endocrinol Invest; 1978 Jul; 1(3):259-61. PubMed ID: 756876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of HGH after oral administration of L-dopa in normal and obese subjects].
    Carducci Artenisio A; Ragonese F; Albanese MC; Alibrando S; Allegra V
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):946-52. PubMed ID: 4463984
    [No Abstract]   [Full Text] [Related]  

  • 14. [Growth hormone secretion in patients with various types of diabetes mellitus and in healthy persons after L-dopa stimulation].
    Muszyński J
    Pol Arch Med Wewn; 1983; 69(4-5):341-50. PubMed ID: 6634455
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects.
    Klimes I; Vigas M; Jurcovicová J; Repceková D; Kolesár P
    Diabetes; 1978 Apr; 27(4):396-9. PubMed ID: 640244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus and sexual ateliotic dwarfism: a comparative study.
    Merimee TJ; Fineberg SE; McKusick VA; Hall J
    J Clin Invest; 1970 Jun; 49(6):1096-102. PubMed ID: 5422015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic clearance and production rates of human growth hormone.
    Taylor AL; Finster JL; Mintz DH
    J Clin Invest; 1969 Dec; 48(12):2349-58. PubMed ID: 5355346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor alteration in schizophrenia: neuroendocrine evidence.
    Rotrosen J; Angrist BM; Gershon S; Sachar EJ; Halpern FS
    Psychopharmacology (Berl); 1976 Dec; 51(1):1-7. PubMed ID: 827770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-dopa, growth hormone and adipokinesis in the lean and the obese.
    Pinter EJ; Tolis G; Friesen HG
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):277-80. PubMed ID: 1165135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.